Trademark Overview
On Monday, June 30, 2025, a trademark application was filed for OCULAR THERAPEUTIX with the United States Patent and Trademark Office. The USPTO has given the OCULAR THERAPEUTIX trademark a serial number of 99259760. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 30, 2025. This trademark is owned by OCULAR THERAPEUTIX, INC.. The OCULAR THERAPEUTIX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, macular degeneration, and lowering intraocular pressure, namely, ophthalmic pharmaceutical preparations that are delivered using implantable intravitreal drug delivery devices that are filled and sold with ophthalmic pharmaceutical preparations; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, and macular degeneration; Pharmaceutical preparations for the treatment of lowering intraocular pressure; Pharmaceutical preparations for the treatment of eye diseases and conditions, namely, dexamethasone that is delivered using implantable intravitreal drug delivery devices that are filled and sold with dexamethasone; Pharmaceutical preparations for the treatment of post-op pain and inflammation of the eye, and itching associated wit...
Research and development in the field of pharmaceuticals and biopharmaceuticals; Product development in the field of pharmaceutical and biopharmaceutical preparations, inserts, implants, and medicines; Development of pharmaceutical preparations and medicines; Product development in the field of pharmaceuticals and biopharmaceuticals